Lifemed AI joins MEDITECH Alliance to bring claims automation to hospitals

What the partnership covers

According to the announcement, Lifemed's formal partnership with MEDITECH comes through an Accelerator-level membership in the MEDITECH Alliance program. The designation gives Lifemed a route to MEDITECH's hospitals and health systems nationwide with DeepClaim, a deep-learning neural network platform the company says is purpose-built to eliminate claims denials, automate revenue cycle workflows and recover lost reimbursement.

As an Accelerator-level member, Lifemed will work directly with MEDITECH's sales and marketing teams to bring DeepClaim and a second product, Gateway, to health systems in the MEDITECH network. Lifemed says integration comes at no cost to health systems from either MEDITECH or Lifemed.

How DeepClaim and Gateway work

Lifemed describes a two-part platform that spans the revenue cycle, from the first patient interaction through final reimbursement.

• DeepClaim is the flagship Revenue Cycle Automation platform. According to Lifemed, it analyzes every claim at the individual line-item level before submission, applies payer-specific rules and inference to fix problems autonomously, and flags the remainder for human review.
• Appeals handling: when denials do occur, DeepClaim automates the appeals and resubmission process end to end, identifying the root cause and routing the resolution without manual intervention, the company says.
• Gateway is the patient access and registration platform. It integrates directly with MEDITECH to automate eligibility verification, insurance discovery and patient intake, so that accurate payer information is captured at the point of service.

Lifemed claims the result is fewer claim rejections, faster reimbursement and a measurably cleaner revenue cycle from day one. It adds that cleaner claims also mean less rework for payers, which lowers administrative cost on both sides.

The problem Lifemed is targeting

The company points to claims denials as a major financial drain. In its words, health systems lose billions of dollars annually to denials, many of which stem from preventable errors introduced long before a claim reaches a payer. Manual processes across patient registration, coding and claims submission create downstream risk such as denied claims, delayed reimbursement and revenue that is written off rather than pursued.

Lifemed also describes a technology gap. Payers have invested heavily in analytics and automation to manage billing complexity at scale, while most health systems still work these processes manually. For organizations already operating on thin margins, the company says, that is a direct threat to financial sustainability.

What it means for health systems

Health systems in the MEDITECH network are invited to request a complimentary DeepClaim analysis. According to Lifemed, it shows what is driving an organization's denials and revenue leakage today and gives a concrete projection of the impact DeepClaim can deliver. Details are available at lifemed.ai.

Marco DeMello, CEO and Co-founder of Lifemed, said the tools most health systems use "haven't kept pace" with billing complexity, and called the partnership a signal that "Revenue Cycle Automation is becoming foundational infrastructure." Jeff Kimball, Associate Vice President of Business Development at MEDITECH, said that integrating Lifemed's technologies "strengthens our EHR platform, giving our healthcare customers improved financial visibility and boosted operational productivity."

The performance claims in the announcement come from Lifemed itself, and the release does not include figures on denial reductions or recovered revenue. The free analysis is the route the company offers for hospitals to see projected results for their own claims.